Top Markets
Coin of the day
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rank in Stocks #6896
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Share Price
$14.30
Last synced: 2023-06-29
Market Cap
$1.81B
Change (1 day)
-2.81%
Change (1 year)
0.00%
Country
CA
Trade BELLUS Health Inc. (BLU)

Category

Dividend yield history for BELLUS Health Inc. (BLU)
BELLUS Health Inc. (stock symbol: BLU) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for BELLUS Health Inc. (BLU) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH